Webbplatsen kommer inte fungerar helt korrekt om er webbläsares JavaScript funktion är inaktiverad.
A unique neuromuscular treatment

Myoroface

MYoroface has developed, produced, patented and registered IQoro®, a new and unique neuromuscular treatment method that requires just 30 seconds’ exercise, three times per day. It works by training and strengthening the muscles, and by stimulating the brain to regenerate the pathways that control them. IQoro® helps people with swallowing problems, hiatus hernia, facial paralysis, speech, snoring or sleep apnoea problems and more. The product and its training regime is based in over two decades of research. 

Myoroface

CEO:

Ylvali Gerling

First investment year:

2013

Business sector:

Life Science, Medtech

Investment manager: Marie Andersson Visit website